1 |
Anton, A. H. and Sayre, D. F., A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther., 138, 360-375 (1962)
|
2 |
Bunn, S. J. and Dunkley, P. R., Opioid inhibition of nicotineinduced -uptake into cultured bovine adrenal medullary cells. Biochem. Pharmacol., 41, 715-722 (1991)
DOI
ScienceOn
|
3 |
Challis, R. A. J., Jones, J. A., Owen, P. J., and Boarder, M. R., Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J. Neurochem., 56, 1083-1086 (1991)
DOI
PUBMED
|
4 |
Dean, D. M., Lemaire, S., and Livett, B. G., Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors. J. Neurochem., 38, 606-614 (1982)
DOI
PUBMED
|
5 |
Lim, D. Y., Kim, C. D., and Ahn, K. W., Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch. Pharm. Res., 15(2), 115-125 (1992)
DOI
ScienceOn
|
6 |
Marley, P. D. and Livett, B. G., Effects of opioid compounds on desensitization of the nicotinic response of isolated bovine adrenal chromaffin cells. Biochem. Pharmacol., 36(8), 2937-2944 (1987)
DOI
ScienceOn
|
7 |
Marley, P. D., Mitchelhill, K. I., and Livett, B.G., Effects of opioid peptides containing the sequence of -enkephalin or -enkephalin on nicotine-induced secretion from bovine adrenal chromaffin cells. J. Neurochem., 46, 1-11 (1986)
DOI
PUBMED
|
8 |
Uyama, Y., Imaizumi, Y., and Watanabe, M., Effects of cyclopiazonic acid, a novel -ATPase inhibitor on contractile responses in skinned ileal smooth muscle. Br. J. Pharmacol., 106, 208-214 (1992)
DOI
ScienceOn
|
9 |
Wakade, A. R., Studies on secretion of catecholamines evoked by ACh or transmural stimulation of the rat adrenal gland. J. Physiol., 313, 463-480 (1981)
DOI
|
10 |
Goeger, D. E. and Riley, R. T., Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on binding and permeability. Biochem. Pharmacol., 38, 3995-4003 (1989)
DOI
ScienceOn
|
11 |
Dermitzaki, E., Gravanis, A., Venihaki, M., Stournaras, C., and Margioris, A. N., Opioids suppress basal and nicotineinduced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology, 142(5), 2022-2031 (2001)
DOI
ScienceOn
|
12 |
Lim, D. Y., Lee, J. J., and Choi, C. H., Effect of opioid on nicotinic receptor-mediated catecholamine secretion in the rat adrenal gland. Korean J. Pharmacol., 28(2), 181-190 (1992)
|
13 |
Conway, E. L., Brown, M. J., and Dollery, C. T., Studies on the pharmacology of central opioid-induced increases in plasma catecholamines in conscious rats. Neuropharmacol., 23(11), 1291-1296 (1984)
DOI
ScienceOn
|
14 |
Douglas, W. W., Kanno, T., and Sampson, S. R., Influence of the ionic environment on the membrane potential of adrenal cells and on the depolarizing effect of acetylcholine. J. Physiol., 191, 107-121 (1967)
DOI
PUBMED
|
15 |
Kleppisch, T., Ahnert-Hilger, G., Gollasch, M., Spicher, K., Hescheler, J., Schultz, G., and Rosenthal, W., Inhibition of voltage-dependent channels via -adrenergic and opioid receptors in cultured bovine adrenal chromaffin cells. Pflugers Arch., 421, 131–137 (1992)
DOI
|
16 |
Ritchie, A. K., Catecholamine secretion in a rat pheochromocytoma cell line: Two pathways for calcium entry. J. Physiol., 286, 541-561 (1979)
DOI
|
17 |
Albillos, A., Gandía, L., Michelena, P., Gilabert, J. A., del Valle, M., Carbone, E., and García, A.G., The mechanism of calcium channel facilitation in bovine chromaffin cells. J. Physiol., 494, 687-695 (1996)
DOI
|
18 |
Saiani, L. and Guidotti, A., Opiate receptor-mediated inhibition of catecholamine release in primary cultures of bovine adrenal chromaffin cells. J. Neurochem., 39, 1669–1676 (1982)
DOI
|
19 |
Suzuki, M., Muraki, K., Imaizumi, Y., and Watanabe, M., Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum -pump, reduces -dependent currents in guineapig smooth muscle cells. Br. J. Pharmacol., 107, 134-140 (1992)
DOI
ScienceOn
|
20 |
Artalejo, C. R., Adams, M. E., and Fox, A. P., Three types of channel trigger secretion with different efficacies in chromaffin cells. Nature, 367, 72-76 (1994)
DOI
ScienceOn
|
21 |
DougIas, W. W., Kanno, T., and Sampson, S. R., Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells : An analysis employing techniques of tissue culture. J. Physiol., 188, 107-120 (1967)
DOI
|
22 |
Tallarida, R. J. and Murray, R. B., Manual of pharmacologic calculation with computer programs. 2nd Ed. New York, Speringer-Verlag, pp.132, (1987)
|
23 |
Winkler, H. and Westhead, E., The molecular organization of adrenal chromaffin granules. Neuroscience, 5, 1803-1823 (1980)
DOI
PUBMED
ScienceOn
|
24 |
Hammer, R. and Giachetti, A., Muscarinic receptor subtypes: and biochemical and functional characterization. Life Sci., 31, 2992-2998 (1982)
DOI
ScienceOn
|
25 |
Kumakura, K., Karoum, F., Guidotti, A., and Costa, E., Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature, 283, 489-492 (1980)
DOI
ScienceOn
|
26 |
Garcia, A. G., Sala, F., Reig, J. A., Viniegra, S., Frias, J., Fonteriz, R., and Gandia, L., Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature, 309, 69-71 (1984)
DOI
ScienceOn
|
27 |
O'Farrell, N., Zigas, J., and Marley, P. D., Effect of N- and L-type calcium channel antagonists and ()-Bay-K-8644 on nerveinduced catecholamine secretion from bovine perfused adrenal glands. Br. J. Pharmacol., 121, 381-388 (1997)
DOI
PUBMED
ScienceOn
|
28 |
Jarry, H., Dietrich, M., Barthel, A., Giesler, A., and Wuttke, W., In vivo demonstration of a paracrine, inhibitory action of Metenkephalin on adrenomedullary catecholamine release in the rat. Endocrinology, 125, 624-629 (1989)
DOI
ScienceOn
|
29 |
Livett, B. G. and Boksa, P., Receptors and receptor modulation in cultured chromaffin cells. Can. J. Physiol. Pharmacol., 62, 467-476 (1984)
DOI
ScienceOn
|
30 |
Mannelli, M., Maggi, M., DeFeo, M. L., Boscaro, M., Opocher, G., Mantero, F., Baldi, E., and Giusti, G., Opioid modulation of normal and pathological human chromaffin tissue. J. Clin. Endocrinol. Metab., 62, 577-582 (1986)
DOI
|
31 |
Cheek, T. R., O'Sullivan, A. J., Moreton, R. B., Berridge, M. J., and Burgoyne, R. D., Spatial localization of the stimulusinduced rise in cytosolic in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS Lett., 247, 429-434 (1989)
DOI
ScienceOn
|
32 |
Kitamura, G., Ohta, T., Kai, T., Kon, Y., and Ito, S., Inhibitory effects of opioids on voltage-dependent channels and catecholamine secretion in cultured porcine adrenal chromaffin cells. Brain Res., 942(1-2), 11-22 (2002)
DOI
PUBMED
ScienceOn
|
33 |
Barron, B. A. and Hexum, T. D., Modulation of bovine adrenal gland secretion by etorphine and diprenorphine. Life Sci., 38, 935-940 (1986)
DOI
ScienceOn
|
34 |
Boarder, M. R., Marriott, D., and Adams, M., Stimulus secretion coupling in cultured chromaffin cells, dependency on external sodium and on dihydropyridine-sensitive calcium channels. Biochem. Pharmacol., 36, 163-167 (1987)
DOI
ScienceOn
|
35 |
Epple, A., Nibbio, B., Spector, S., and Brinn, J. E., Endogenous codeine: autocrine regulator of catecholamine release from chromaffin cells. Life Sci., 54(11), 695-702 (1994)
DOI
ScienceOn
|
36 |
Kimura, T., Katoh, M., and Satoh, S., Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: Evidence for the functional role of opioid receptors. J. Pharmacol. Exp. Ther., 244(3), 1098-1102 (1988)
|
37 |
Tome, A. R., Izaguirre, V., Rosario, L. M., Cena, V., and Gonzalez- Garcia, C., Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells. Brain Res., 903(1-2), 62-65 (2001)
DOI
PUBMED
ScienceOn
|
38 |
Dendorfer, A. and Dominiak, P., Characterisation of bradykinin receptors mediating catecholamine release in PC12 cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 274-281 (1995)
|
39 |
Ilno, M., Calcium-induced calcium release mechanism in guinea pig taenia caeci. J. Gen. Physiol., 94, 363-383 (1989)
DOI
PUBMED
ScienceOn
|
40 |
Seidler, N. W., Jona, I., Vegh, N., and Martonosi, A., Cyclopiazonic acid is a specific inhibitor of the -ATPase of sarcoplasimc reticulum. J. Biol. Chem., 264(30), 17816-17823 (1989)
|
41 |
Twitchell, W. A. and Rane, S. G., Opioid peptide modulation of -dependent and voltage-activated currents in bovine adrenal chromaffin cells. Neuron, 10, 701-709 (1993)
DOI
ScienceOn
|
42 |
Lemaire, S., Day, R., Dumont, M., Chouinard, L., and Calvert, R., Dynorphin and enkephalins in adrenal paraneurons. Opiates in adrenal medulla. Can. J. Physiol. Pharmacol., 62, 484-492 (1984)
DOI
ScienceOn
|
43 |
Livett, B. G., Dean, D. M., Whelan, L. G., Udenfriend, S., and Rossier, J., Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature, 289, 317-319 (1981)
DOI
ScienceOn
|
44 |
Lopez, M. G., Fonteriz, R., Gandia, L., De la Fuente, M., Villarroya, M., Garcia-Sancho, J., and Garcia, A. G., The nicotinic ACh receptor of the bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol. Molec. Biol., 247, 199-207 (1993)
DOI
ScienceOn
|
45 |
Cena, V., Nicholas, G., Sanchez-Garcia, P., Kjrpekar, S. M., and Garcia, A. G., Pharmacological dissection of receptorassociated and voltage-sensitive ionic channeIs involved in catecholamine release. Neuroscience, 10, 1455-1462 (1983)
DOI
ScienceOn
|
46 |
Owen, P. J., Marriott, D. B., and Boarder, M. R., Evidence for a dihydropyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br. J. Pharmacol., 97, 133-138 (1989)
DOI
ScienceOn
|